Back to search
FDAFDA · Food and drugs·Recall number D-0072-2023

Desmopressin Acetate Tablets 0.2mg, 100-count bottles, RX Only, Distributed by: Avet Pharmaceuticals Inc. East Brunswick, NJ 08816, NDC 23155-490-01

Published December 7, 2022 · Recall initiated: November 23, 2022

Summary

FDA records drug Class II recall D-0072-2023, published December 7, 2022 and initiated November 23, 2022. Recalling firm: Heritage Pharmaceuticals Inc; Status: Terminated; Reported quantity: 13805 Bottles each containing 100 tablets; Lot: Lot #: 220440A, Exp. Date 05/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug

What to do

Voluntary: Firm initiated · Letter

Get an email if DESMOPRESSIN ACETATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DESMOPRESSIN ACETATE
Manufacturer
Heritage Pharmaceuticals Inc
Distributor
Nationwide within the United States
Lot
Lot #: 220440A, Exp. Date 05/2024
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Desmopressin Acetate Tablets 0.2mg, 100-count bottles, RX Only, Distributed by: Avet Pharmaceuticals Inc. East Brunswick, NJ 08816, NDC 23155-490-01 recalled?

Yes. FDA published recall D-0072-2023 on December 7, 2022. Reported hazard: Subpotent Drug

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DESMOPRESSIN ACETATE.